Utilization of Pharmacy Claims Data to Evaluate Therapeutic Interchange
). In analyzing this program, the authors describe a simple methodology for comparing actual conversion doses utilized to that of guideline recommendations. We also compare rates of dosage titrations and discuss the findings as they pertain to the conduct and evaluation of future therapeutic interchange programs.
METHODOLOGY

Sample population
Potential study candidates were identified from automated ACE I prescription claims. These records were extracted from prescription claims tapes and imported to an Access database in which selection criteria were used to identify study members with a high probability of being part of the therapeutic interchange process. Three inclusion criteria were used: 
Calculation of Dosing Ratios
The dosing ratio used to convert each patient between products was calculated from the pharmacy claim by dividing the total daily dose of the post-switch medication by the total daily dose of the preswitch medication. For example, if a patient was converted from 10 mg of product A to 10 mg of product B, he or she was given a dosing ratio of 1 
